Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
Xavier Thomas(Hôpital Lyon Sud), D Fière(National Institutes of Health), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse), Agnès Buzyn(Hôpital Saint-Jacques), Véronique Lhéritier(Hospices Civils de Lyon), Pierre Fenaux(Saint Louis University Hospital), Claude Boucheix(Inserm), Olivier Tournilhac, Norbert Vey(Centre de Recherche en Cancérologie de Marseille), Aspasia Stamatoullas(European Union), Nathalie Fegueux(European Union), Jean Gabert(Hôpital Nord), Jean-Paul Vernant(Hôpital Edouard Herriot), Tibor Kovacsovics(Hôpital Edouard Herriot), Jean-Michel Boiron(Hôpital Edouard Herriot), C Charrin(Hôpital Edouard Herriot), Ken Bradstock(Hôpital Edouard Herriot), Oumédaly Reman(Centre Hospitalier Universitaire de Caen), André Delannoy(Hôpital Saint-Jacques), Hervé Dombret(University of London Institute in Paris)
Cited by 547
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k